Cargando…
Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
The COVID-19 pandemic has redemonstrated the importance of the fungal-after-viral phenomenon, and the question of whether prophylaxis should be used to prevent COVID-19-associated pulmonary aspergillosis (CAPA). A distinct pathophysiology from invasive pulmonary aspergillosis (IPA), CAPA has an inci...
Autores principales: | Hawes, Armani M., Permpalung, Nitipong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774425/ https://www.ncbi.nlm.nih.gov/pubmed/36551361 http://dx.doi.org/10.3390/antibiotics11121704 |
Ejemplares similares
-
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
por: Permpalung, Nitipong, et al.
Publicado: (2021) -
Aspergillus lentulus: An Under-recognized Cause of Antifungal Drug-Resistant Aspergillosis
por: Nematollahi, Saman, et al.
Publicado: (2021) -
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
por: Hatzl, Stefan, et al.
Publicado: (2021) -
Coronavirus Disease 2019–Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics
por: Permpalung, Nitipong, et al.
Publicado: (2023) -
Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis
por: Permpalung, Nitipong, et al.
Publicado: (2016)